Evidence map›Paper›PMID 37909174›Full record

ArticleJournal of the International AIDS Society2023

Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.

Michelle A Bulterys, Irene Njuguna, Maureen King'e, Daisy Chebet, Hellen Moraa, Laurén Gomez, Alvin Onyango, Kenneth Malavi, Gladys Nzia, Martin Chege and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Michelle A BulterysDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-9403-5084
Irene NjugunaDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4250-3231
Maureen King'eDepartment of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Daisy ChebetDepartment of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Hellen MoraaKenyatta National Hospital, Nairobi, Kenya.
Laurén GomezDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Alvin OnyangoKenyatta National Hospital, Nairobi, Kenya.
Kenneth MalaviKenyatta National Hospital, Nairobi, Kenya.
Gladys NziaKenyatta National Hospital, Nairobi, Kenya.
Martin ChegeKenyatta National Hospital, Nairobi, Kenya.
Jillian NearyDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.
Anjuli D WagnerDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Kendall A LawleyDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Dalton WamalwaDepartment of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Sarah Benki-NugentDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-4301-1573
University of Washington · USKenyatta National Hospital · KEUniversity of Nairobi · KE

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)P30MH123248 · NIMH · UNIVERSITY OF WASHINGTON · PI SIMONI, JANE M. · 2021 to 2024
$5.8M
HEU outcomes: population-evaluation and screening strategies (HOPE)R33HD103079 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2022 to 2024
$2.6M
Testing implementation strategies to improve delivery of PrEP for pregnant and postpartum women in KenyaK01MH121124 · NIMH · UNIVERSITY OF WASHINGTON · PI WAGNER, ANJULI DAWN · 2019 to 2023
$835k
Understanding the role of schools in supporting HIV treatment outcomes among HIV infected adolescentsK43TW011422 · FIC · KENYATTA NATIONAL HOSPITAL · PI NJUGUNA, IRENE NYAMBURA · 2020 to 2024
$603k
FIC NIH HHS K43 TW011422NIAID NIH HHS T32 AI007140NICHD NIH HHS R33 HD103079NIMH NIH HHS K01 MH121124NIMH NIH HHS P30 MH123248
6 · The paper itself

Abstract

introductionPredictors of neurodevelopment among children who are HIV-exposed uninfected (CHEU) are poorly understood.

methodsMothers with and without HIV and their children were enrolled during 6-week postnatal care visits across seven sites in Kenya between March 2021 and June 2022. Infant neurodevelopment was assessed using the Malawi Developmental Assessment Tool, including social, language, fine motor and gross motor domains. We used multivariate linear mixed effects models to identify associations between 1-year neurodevelopment scores, HIV and antiretroviral therapy (ART) exposures, and household factors, adjusted for potential confounders and clustered by the site.

resultsAt 1-year evaluation, CHEU (n = 709) and children who are HIV-unexposed uninfected (CHUU) (n = 715) had comparable median age (52 weeks) and sex distribution (49% vs. 52% female). Mothers living with HIV were older (31 vs. 27 years), had lower education (50% vs. 26% primary) and were more likely to be report moderate-to-severe food insecurity (26% vs. 9%) (p < 0.01 for all). Compared to CHUU, CHEU had higher language scores (adjusted coeff: 0.23, 95% CI: 0.06, 0.39) and comparable social, fine and gross motor scores. Among all children, preterm birth was associated with lower gross motor scores (adjusted coeff: -1.38, 95% CI: -2.05, -0.71), food insecurity was associated with lower social scores (adjusted coeff: -0.37, 95% CI: -0.73, -0.01) and maternal report of intimate partner violence (IPV) was associated with lower fine motor (adjusted coeff: -0.76, 95% CI: -1.40, -0.13) and gross motor scores (adjusted coeff: -1.07, 95% CI: -1.81, -0.33). Among CHEU, in utero efavirenz (EFV) exposure during pregnancy was associated with lower gross motor scores compared to dolutegravir (DTG) exposure (adjusted coeff: -0.51, 95% CI: -1.01, -0.03). Lower fine and gross motor scores were also associated with having a single or widowed mother (adjusted coeff: -0.45, 95% CI: -0.87, -0.03) or a deceased or absent father (adjusted coeff: -0.81, 95% CI: -1.58, -0.05), respectively.

conclusionsBiologic and social factors were associated with child neurodevelopment. Despite socio-demographic differences between CHEU and CHUU, 1-year neurodevelopment was similar. Addressing IPV and food insecurity may provide benefits regardless of maternal HIV status. DTG use was associated with higher neurodevelopmental scores in CHEU, compared to EFV regimens, potentially contributing to a lack of neurodevelopmental difference between CHEU and CHUU.

Indexed as

HIV InfectionsPregnancy Complications, InfectiousPremature BirthAlkynesBenzoxazinesChildChild DevelopmentCyclopropanesFemaleHumansInfantInfant, NewbornKenyaMaleMothersPregnancyAlkynesBenzoxazinesCyclopropanesefavirenzCHEUchildren who are HIV-exposed uninfectedHIV exposureintimate partner violencematernal mental healthneurodevelopment

Identifiers

PMID37909174
PMCPMC10618871
OpenAlexW4388110943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.